Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Qihan Biotech

Request full access

Qihan Biotech is a Healthcare Start Up Based in Hangzhou

Hangzhou, ChinaFounded 2017Biotech & Life Sciences

About Qihan Biotech

Qihan Biotech is a leading biotechnology startup based in Hangzhou, China, that specializes in the development of stem cell-derived cell therapy products. The company leverages its world-class capabilities in multiplexable gene editing, a process that allows for the simultaneous modification of multiple genes, to create innovative treatments for various diseases.

The company's primary focus is on the development of therapies for immune-privileged diseases, which are conditions that the immune system typically does not respond to. Qihan Biotech's products are designed to modify the genome of cells to make them immune-privileged, thereby enabling the body's immune system to fight off these diseases.

Qihan Biotech recently completed a pre-Series B financing round, raising over $16 million. This funding will be used to further develop and commercialize its cell therapy products. The company's business model revolves around the research, development, and sale of these innovative therapies.

One of Qihan Biotech's most promising products is QN-019a, a multi-locus gene-editing cell therapy product designed to treat CD19-positive B-Cell Lymphoma. The company recently received approval from the National Medical Products Administration (NMPA) to begin clinical trials for this product.

Qihan Biotech operates in the rapidly growing market of gene therapy and stem cell research. Its potential clients include hospitals, research institutions, and patients suffering from diseases that are currently untreatable with conventional therapies.

In summary, Qihan Biotech is a pioneering biotech startup that uses advanced gene editing techniques to develop innovative cell therapy products. The company's successful fundraising efforts and regulatory approvals indicate a promising future in the burgeoning field of gene therapy.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2017
Headquarters
Hangzhou, China
Employees
7
Open positions
None listed
Dealroom signal
65.8/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VCOther financing Sep 2023 $14M $335M Zhejiang Industrial Fund ↗
SERIES AOther financing Mar 2021 $67M $268M Lilly Asia Ventures · Sequoia · CMB International · Matrix Partners China —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Qihan Biotech website traffic

Latest recorded traffic for Qihan Biotech is 9.8K monthly website visits, up 117.8% over the last three months. Qihan Biotech's team declined 22.2% over the past year.

Latest monthly visits9.8K 3-month web change+117.8% 1-year team growth-22.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Qihan Biotech in the Hangzhou ecosystem

Live from Dealroom

The Qihan Biotech office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A12 investors entered at this stage

Other known investors1 additional known investor

  • Harvard University
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Qihan Biotech on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Qihan Biotech’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.